Welcome to Animal Health, your reference Website

We belong to the VISAVET Research Centre from the Complutense University of Madrid (UCM). We work in research and teaching on animal infectious diseases.

 
  • Vigiasan: Proyecto de Innovación Empleo de Tecnologías para evaluar el estado de salud, bienestar y productividad en ganado

  • VACDIVA quiere resolver el problema de la Peste Porcina Africana (PPA) en Europa y en los países afectados, desarrollando vacunas seguras y efectivas para cerdos domésticos y jabalíes, tests de diagnóstico y herramientas para estrategias de control y erradicación en Europa
  • Proyecto de Innovación "Empleo de Tecnologías para evaluar el estado de salud, bienestar y productividad en ganado"
  • Somos Laboratorio de Referencia de la Organización Mundial de la Sanidad Animal (OIE) en Peste Porcina Africana (PPA) y Peste Equina Africana PEA.
  • Realizamos el diagnóstico de los principales virus que afectan a las abejas, siendo pioneros en el desarrollo y puesta a punto de nuevas técnicas para su estudio.
  • La investigación epidemiologica de la Peste Porcina Clásica y Africana (PPC y PPA) son dos de nuestras prioridades.

Featured

African Swine Fever African Swine Fever videos African Swine Fever Map
 
Marine Animal Health VACDIVA ASF NIFNAF

New research article published in Frontiers in Immunology

Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses.

ResumenAbstractgrown considerably in the last decade causing important economic consequences for the swine industry. Its control is hampered by the lack of an effective treatment or vaccine. In Europe, the wild boar is a key wild reservoir for ASF. The results of the oral vaccination trial of wild boar with Lv17/WB/Rie1 are hope for this problem. However, this vaccine candidate has certain safety concerns, since it is a naturally attenuated vaccine. Therefore, the current study aims to evaluate the safety of this vaccine candidate in terms of overdose (high dose) and repeated doses (revaccination) in wild boar. Low-dose orally vaccinated animals developed only a slight transient fever after vaccination and revaccination. This was also the case for most of the high-dose vaccinated wild boar, except for one of them which succumbed after revaccination. Although this fatality was related to hierarchical fights between animals, we consider that further studies are required for clarification. Considering these new results and the current epidemiological situation of ASF in wild boar, this vaccine prototype is a promising tool for the control of the disease in these wild populations, although further studies are needed.

Barasona JA, Cadenas-Fernández E, Kosowska A, Barroso-Arévalo S, Rivera B, Sánchez R, Porras N, Gallardo C and Sánchez-Vizcaíno JM.

 Open access article

Isabel Mínguez Tudela Award for Innovation in Animal Health

José Manuel Sánchez-Vizcaíno, professor of Animal Health at the Complutense University of Madrid (UCM) and researcher at the Veterinary Health Surveillance Center (VISAVET), and Marisa Arias, director of the Animal Health Research Center (CISA-INIA), have been awarded the VII Isabel Mínguez Tudela Prize for Innovation in Animal Health during the XII Annual Conference of the Vet + i Foundation, held this Thursday, November 25, 2021.

Read the article in the Animal's Health magazine (spanish text)